Page last updated: 2024-08-21

oleanolic acid and Hepatitis C

oleanolic acid has been researched along with Hepatitis C in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hou, MC; Huang, YH; Lan, KH; Lan, KL; Lee, WP; Liao, SX1
Akahori, Y; Hasegawa, H; Hijikata, M; Nio, Y; Okamura, H; Oshima, M; Ryo, A; Sasai, M; Tanaka, Y; Wakita, T; Watashi, K1
Fang, X; Kong, L; Li, S; Liao, Q; Sun, R; Wang, J; Wu, X; Zhang, Q; Zhang, Y; Zhu, X; Zhu, Y1
Chang, SP; Chung, CY; Hsu, WC; Hung, TC; Li, CF; Lin, CC; Lin, LT; Richardson, CD; Russell, RS; Shields, J; Tyrrell, DL; Yen, MH1
Kumada, H; Tsubota, A1
Iwabuchi, S; Osada, T; Takatori, M; Yoshida, H1

Reviews

2 review(s) available for oleanolic acid and Hepatitis C

ArticleYear
[Therapeutic strategies for hepatitis C].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 7, Issue:Pt 1

    Topics: Antiviral Agents; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Interferons; Oleanolic Acid; Pharmacogenetics; Phlebotomy; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Ursodeoxycholic Acid

2004
[Long-term interferon (IFN), neominophagen C (SNMC) combination therapy of active liver cirrhosis type C].
    Nihon rinsho. Japanese journal of clinical medicine, 1994, Volume: 52, Issue:7

    Topics: Biomarkers; Cysteine; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Glycine; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Middle Aged; Oleanolic Acid; RNA, Viral

1994

Other Studies

4 other study(ies) available for oleanolic acid and Hepatitis C

ArticleYear
Antiviral effect of saikosaponin B2 in combination with daclatasvir on NS5A resistance-associated substitutions of hepatitis C virus.
    Journal of the Chinese Medical Association : JCMA, 2019, Volume: 82, Issue:5

    Topics: Antiviral Agents; Carbamates; Cells, Cultured; Drug Resistance, Viral; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Imidazoles; Oleanolic Acid; Pyrrolidines; Saponins; Valine; Viral Nonstructural Proteins; Virus Replication

2019
Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems.
    Antiviral research, 2019, Volume: 169

    Topics: Antiviral Agents; Cell Line; Cell Proliferation; Coinfection; DNA, Viral; Heme Oxygenase-1; Hep G2 Cells; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Hepatocytes; Humans; NF-E2-Related Factor 2; Oleanolic Acid; Virus Replication

2019
Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity.
    Antiviral research, 2013, Volume: 98, Issue:1

    Topics: Antiviral Agents; Cell Line; Down-Regulation; Drugs, Chinese Herbal; Hepacivirus; Hepatitis C; Humans; Ligustrum; Oleanolic Acid; Replicon; Triterpenes; Ursolic Acid; Viral Nonstructural Proteins; Virus Replication

2013
Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Journal of hepatology, 2015, Volume: 62, Issue:3

    Topics: Animals; Antiviral Agents; Bupleurum; Cell Line; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Liver Transplantation; Male; Oleanolic Acid; Plant Extracts; Rats; Rats, Sprague-Dawley; Saponins; Virion; Virus Internalization; Virus Replication

2015